npc 15437 and ag-490

npc 15437 has been researched along with ag-490 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, BL; Coy, DH; Datta, R; Rossowski, WJ; Taylor, JE	1

Other Studies

1 other study(ies) available for npc 15437 and ag-490

Article	Year
Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. European journal of pharmacology, 2002, Mar-08, Volume: 438, Issue:3 Topics: Alkaloids; Animals; Aorta, Thoracic; Benzophenanthridines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Genistein; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Peptide Fragments; Peptides, Cyclic; Phenanthridines; Piperidines; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; rho-Associated Kinases; Tyrphostins; Urotensins; Vasoconstriction	2002

Article

Year

Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.

European journal of pharmacology, 2002, Mar-08, Volume: 438, Issue:3

Topics: Alkaloids; Animals; Aorta, Thoracic; Benzophenanthridines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Genistein; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Peptide Fragments; Peptides, Cyclic; Phenanthridines; Piperidines; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; rho-Associated Kinases; Tyrphostins; Urotensins; Vasoconstriction

2002